Drug Profile
Pentamycin - Lumavita
Alternative Names: Antibiotic A-246; Cogomycin; FemiFect; Fungichromin; Lagosin; LMV-602; N-Pent; NP 401; NP 402; NP 403; NP 404; Pruri-Ex; SPK-0602Latest Information Update: 11 Mar 2015
Price :
$50
*
At a glance
- Originator Necura Pharmaceuticals AG
- Developer Lumavita; Necura Pharmaceuticals AG
- Class Anti-infectives; Macrolides; Polyenes; Small molecules
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Vaginitis
- Discontinued Cancer; Candidiasis; Intestinal infections; Skin and soft tissue infections
Most Recent Events
- 11 Mar 2015 Discontinued - Preclinical for Vaginitis (LMV 602) in Switzerland (Vaginal)
- 11 Mar 2015 No recent reports on development identified - Preregistration for Vaginitis in Asia, Commonwealth of Independent States, Latin America and North Africa (Vaginal)
- 11 Mar 2015 No recent reports on development identified - Registered for Vaginitis in Switzerland (Vaginal)